1. Company Information :
Logo société
| Company name | SIPHAT |
| Date of creation | 10 april 1989 |
| Legal Form | Limited Company |
| National Company Register | 029999J |
| Sector | Health Care |
| Special legislation | Law 85-91 of 22/11/1985, regulating the manufacture and registration of medicines intended for human use. - Law 88-61 of 02/06/1988 promulgating the VAT code and Law 93-120 of 27/12/1993 promulgating the code of incentives for investments with regard to the importation of capital goods. |
| Social object | Development, manufacture, control, and marketing of medicines for human use. |
| Corporate address | Fondouk Choucha 2013 Ben Arous |
| Phone | +216 71 381 222 |
| Corporate Website | http://www.siphat.rns.tn/ |
| siphat@rns.tn | |
| Listing date and listing modality | 02/05/2001 |
| ISIN code | TN0006670012 |
| Market | Main Market |
| Compartment | S |
| Trading Method | Fixing |
| Trading Group | 99 |
2. Shareholder Relations Officer :
| Full Name | Phone | |
|---|---|---|
| Mrs.Wafa Miled | wafa.miladi@siphat.com | +216 52 447 371 |
3. Administration, Management and Control
Chef Executive Officer
Mr.Anis KLOUZ
Board of Directors
OGM-
03/11/2021
| Name or Corporate Name | Quality | Represented by | Term of mandate |
|---|---|---|---|
| Mr. Anis KLOUZ | Chairman | himself | 2019 - 2021 |
| Presidency of the Government | Member | Mrs.Wasila HAMAMI | 2019 - 2022 |
| Ministry of Health | Member | Mr Ridha SAIDI | 2019 - 2022 |
| Ministry of Finance | Member | Mr. Ali MEKKI | 2019 - 2022 |
| Ministry of Development and International Cooperation | Member | Mr. Tarek BOUHLEL | 2019 - 2022 |
| Central Pharmacy of Tunisia | Member | M. Nabil HANI | 2019 - 2022 |
| National Social Security Fund - CNSS | Member | Mr.Imed BEN KHATER | 2019 - 2022 |
| Tunisian Chemical Fertilizer Company - STEC | Member | Mr. Mourad DOGHRI | 2019 - 2022 |
Control
External auditors
| Full Name | Term of mandate |
|---|---|
| Accounting Firm-ABC represented by Maher Kaiida | 2019 - 2021 |
Committees of the Board of Directors
| Committee | Committee President |
|---|---|
4. Main Shareholders:
OGM-
03/11/2021
| Name or Corporate Name | Number of shares | % |
|---|---|---|
| CENTRAL PHARMACY | 1219994 | 67.77 |
| STEC | 219861 | 12.21 |
| Other shareholders holding less than 5% | 360145 | 20.01 |
| Total | 1800000 | 99.99 |
5. Key Indicators & Ratios:
| Key figures in DT (1) | 2019 | 2018 | 2017 |
|---|---|---|---|
| Share capital | 9 000 000 | 9 000 000 | 9 000 000 |
| Book Value | -21 447 422 | -6 927 267 | 7 386 654 |
| Revenues excluding VAT | 24 460 207 | 33 151 493 | 37 367 828 |
| Operating income | -13 649 118 | -10 124 217 | -5 428 852 |
| Earnings (2) | -14 524 947 | -14 266 063 | -7 734 906 |
| Dividend per share | - | - | - |
(1) Disclosed in the consolidated annual financial statements or, failing that, in the individual annual financial statements.
(2) Net income Group share for companies publishing consolidated accounts.
(2) Net income Group share for companies publishing consolidated accounts.
| Ratio | 2019 | 2018 | 2017 |
|---|---|---|---|
| PER (1) | - | - | - |
| PBR (2) | -0,42 | -0,74 | 1,29 |
| Earnings per share | -8,069 | -7,926 | -4,297 |
| Dividend yield % | - | - | - |
(1) Price Earning Ratio
(2) Price to book Value
(2) Price to book Value
6. Share Capital
Capital Structure
| Nature of Securities | Number | % | Nominal (DT) |
|---|---|---|---|
| Ordinary shares | 1800000 | 100 | 5 |
Capital Evolution
| Decision (EGM) | Nominal (DT) | Nature of the operation | Capital evolution | Capital in circulation | ||
|---|---|---|---|---|---|---|
| DT | Equities | DT | Equities | |||
| 1989-04-10 | 100 | Initial Capital |
6580000 |
65800 |
6580000 |
65800 |
| 1989-06-25 | 100 | Capital Increase in kind |
5880000 |
58800 |
12460000 |
124600 |
| 1996-06-14 | 100 | Increase through Incorporation of Reserves |
800000 |
8000 |
13260000 |
132600 |
| 1997-05-30 | 100 | Increase through Incorporation of Reserves |
540000 |
5400 |
13800000 |
138000 |
| 1998-06-06 | 100 | Increase through Incorporation of Reserves |
1000000 |
10000 |
14800000 |
148000 |
| 1999-06-18 | 100 | Increase through Incorporation of Reserves |
1053000 |
10530 |
15853000 |
158530 |
| 2000-06-20 | 100 | Increase through Incorporation of Reserves |
247000 |
2470 |
16100000 |
161000 |
| 2001-02-05 | 100 | Réduction de capital |
10000000 |
100000 |
6100000 |
61000 |
| 2001-02-05 | 5 | Reduction in Nominal Value |
6100000 |
1220000 |
6100000 |
1220000 |
| 2001-02-05 | 5 | Cash Increase |
2900000 |
580000 |
9000000 |
1800000 |
7. Latest publications SIPHAT
SIPHAT - Quarterly activity reports at 30/09/2025
Company SIPHAT, publishes its indicators of activity relative to the 3rd quarter 2025.
SIPHAT - Quarterly activity reports at 30/09/2025
Company SIPHAT, publishes its indicators of activity relative to the 3rd quarter 2025.
SIPHAT - Quarterly activity reports at 30/09/2025
Company SIPHAT, publishes its indicators of activity relative to the 3rd quarter 2025.
8. The instruments of SIPHAT
| Mnemonic | Label | Nature |
|---|---|---|
| SIPHA | SIPHAT | Equity |